Comparison of the effectiveness and safety of two topical delivery systems of a fixed dosed combination of adapalene and clindamycin in the treatment of acne vulgaris, a double arm, open label, observational study - Adapalene 0.1 % and clindamycin 1 % combination

Investigator Initiated Study0 sites0 target enrollmentTBD

ConditionsHealth Condition 1: null- Acne VulgarisHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue

Overview

Phase: 未知
Intervention: Not specified
Conditions: Health Condition 1: null- Acne VulgarisHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue
Sponsor: Investigator Initiated Study
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

4 years ago

Study Type

Interventional

Investigators

Sponsor

Investigator Initiated Study

Eligibility Criteria

Inclusion Criteria

•1\.Patients with acne of mild to moderate as per the Combined Acne Severity Classification.8
•a.Mild acne: fewer than 20 comedones, or fewer than 15 inflammatory lesions or a total lesion count lower than 30
•b.Moderate acne: 20\-100 comedones, or 15\-50 inflammatory lesions or a total lesion count of 30\-125
•c.Severe acne: more than 5 cysts, or comedone count greater than 100, or a total inflammatory count greater than 50, or a total lesion count greater than 125
•2\.Male and female patients aged between 18 to 30 years.
•3\.Subjects willing to comply with study visits and procedure
•4\.Patients taking certain topical and systemic treatments required to undergo 01 month washout periods before they can enter the study.

Exclusion Criteria

•1\. Patients not willing to sign consent form
•2\. Who have a diagnosed hormonal or endocrine cause for acne
•3\. Acne conglobata, acne fulminans, secondary acne, severe acne, or other dermatologic conditions requiring systemic treatment.
•4\. Women are to be excluded if they are pregnant, planning a pregnancy or nursing
•5\. Patients having any contraindication to clindamycin or adapalene
•6\. Men with beards are excluded if these are likely to cause interference with study assessments
•7\. Any significant medical condition which may interfere with the patients optimal participation in the study as per Investigators opinion

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Phase 3

Comparing the Effectiveness and Safety of PDpoetin and cinapoetin in the Remodeling of Anemia in Children with Chronic Renal Failurealpha and Betha erythropoietin, Anemia in CKD.Chronic kidney disease, stage 3 (moderate)

IRCT20180222038824N1Iran University of Medical Sciences40

Completed

Phase 2

Treatment of Psoriasis with IPD admissioHealth Condition 1: null- Psoriasis

CTRI/2018/05/014152Central Council for Research in Unani Medicine120

Completed

Phase 2

Clinical trial on PsoriasisHealth Condition 1: null- Psoriasis

CTRI/2018/05/013636Central Council for Research in Unani Medicine120

Completed

Not Applicable

Comparison of efficacy and safety of two forms of cyclodestructive therapy. Transscleral cyclophotocoagulation and endoscopic cyclophotocoagulation in the treatment of patients with refractory glaucoma.Eye DiseasesEye Diseases: GlaucomaGlaucoma

ISRCTN40743836Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)100

Not yet recruiting

Phase 4

To study the comparison of efficacy and safety between injection iron sucrose complex and injection ferric carboxymaltose in the treatment of moderate anemia in pregnancy.

CTRI/2024/03/064066GMERS Medical college and hospital Gotri,Vadodara